Baicalin (Synonyms: Baicalein 7-O-β-D-glucuronide)

Name: Baicalin
Brand: MedChemExpress
SKU: HY-N0197
Rating: 5.0 (60 reviews)

Cat. No.: HY-N0197 Purity: 98.92%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

Baicalin, as a flavonoid glycoside, is an allosteric carnitine palmityl transferase 1 (CPT1) activator. Baicalin reduces the expression of NF-κB.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No. : 21967-41-9

사이즈	재고	수량
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	해외재고보유	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	해외재고보유	Estimated Time of Arrival: December 31
Solid
100 mg	해외재고보유	Estimated Time of Arrival: December 31
500 mg	해외재고보유	Estimated Time of Arrival: December 31
1 g	해외재고보유	Estimated Time of Arrival: December 31
5 g	해외재고보유	Estimated Time of Arrival: December 31
10 g	견적 받기
50 g	견적 받기

or 대량구매 문의

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 60 publication(s) in Google Scholar

Other Forms of Baicalin:

Baicalin (Standard) In-stock

60 Publications Citing Use of MCE Baicalin

Cell Proliferation/Viability Assay

: Baicalin purchased from MedChemExpress. Usage Cited in: Antioxidants (Basel). 2024 Jan 17;13(1):115. [Abstract]; 20 mg/kg baicalin was administered orally by gavage to mice for 90 days. DHE staining was performed to observe the content of superoxide anions in tissues.

: Baicalin purchased from MedChemExpress. Usage Cited in: Antioxidants (Basel). 2024 Jan 17;13(1):115. [Abstract]; Cells were treated with 5 µM Cd, 10 µM baicalin, and 20 µM NAC, alone or in combination, for 12 h.

: Baicalin purchased from MedChemExpress. Usage Cited in: Antioxidants (Basel). 2024 Jan 17;13(1):115. [Abstract]; Cells were treated with 5 µM Cd, 10 µM baicalin, and 20 µM NAC alone or in combination for 12 h.

: Baicalin purchased from MedChemExpress. Usage Cited in: Oral Dis. 2019 Nov;25(8):1945-1953. [Abstract]; PF and BAI combination suppresses activation of the NF-κB signaling pathway in LPS-treated HOKs. Western blotting assay is performed to investigate expression of NF-κB inflammatory signaling proteins.

: Baicalin purchased from MedChemExpress. Usage Cited in: Oral Dis. 2019 Nov;25(8):1945-1953. [Abstract]; The nuclear translocation of NF-κB p65 was visualized using a laser confocal scanning microscope imaging system. Nuclei detected with DAPI (blue). Cells expressing NF-κB p65 in the cytoplasm (green). NF-κB p65 expresses mostly in the nucleus, and a small amount expressed in the cytoplasm (green). Localization of NF-κB p65 in the cytoplasm (green).

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All NF-κB Isoform Specific Products:

View All Isoforms

NF-κB NF-κB1/p50 RelA/p65 RelB c-Rel

View All HIV Isoform Specific Products:

View All Isoforms

HIV HIV-1 HIV-2

Biological Activity
Protocol
순도&문서
References
고객리뷰

제품 설명

Baicalin, as a flavonoid glycoside, is an allosteric carnitine palmityl transferase 1 (CPT1) activator. Baicalin reduces the expression of NF-κB^[1]^[2]^[3].

IC₅₀ & Target^[1]

NF-κB

CPT-1

Autophagy

Cellular Effect

Cell Line	Type	Value	Description	References
H9	EC₅₀	112 3 Compound: 8	Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay	[PMID: 8158164]
Calu-3	CC₅₀	>100 3 Compound: 2	Cytotoxicity against human Calu-3 cells assessed as inhibition of cell growth incubated for 4 days by MTS assay Cytotoxicity against human Calu-3 cells assessed as inhibition of cell growth incubated for 4 days by MTS assay	[PMID: 36965227]
H9	IC₅₀	72 3 Compound: 8	Cytotoxicity against human H9 cells after 3 days Cytotoxicity against human H9 cells after 3 days	[PMID: 8158164]
CHO	IC₅₀	> 200 3 Compound: 2	Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells	[PMID: 12713409]
CHO	IC₅₀	>200 3 Compound: 2	Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells	[PMID: 12713409]
HUVEC	IC₅₀	> 1000 3 Compound: 2	Inhibition of trypsin-induced elevation in PAI1 production in HUVEC by ELISA Inhibition of trypsin-induced elevation in PAI1 production in HUVEC by ELISA	[PMID: 9214730]
H9	EC₅₀	112 3 Compound: 8	Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay	[PMID: 8158164]
MGC-803	IC₅₀	8.78 3 Compound: 50	Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 5 days by MTT assay Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 5 days by MTT assay	[PMID: 33619958]
H9	IC₅₀	72 3 Compound: 8	Cytotoxicity against human H9 cells after 3 days Cytotoxicity against human H9 cells after 3 days	[PMID: 8158164]
HUVEC	IC₅₀	>1 2 Compound: 2	Inhibition of trypsin-induced elevation in PAI1 production in HUVEC by ELISA Inhibition of trypsin-induced elevation in PAI1 production in HUVEC by ELISA	[PMID: 9214730]
Calu-3	CC₅₀	> 100 3 Compound: 2	Cytotoxicity against human Calu-3 cells assessed as inhibition of cell growth incubated for 4 days by MTS assay Cytotoxicity against human Calu-3 cells assessed as inhibition of cell growth incubated for 4 days by MTS assay	[PMID: 36965227]
MGC-803	IC₅₀	8.78 3 Compound: 5	Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by MTT assay	[PMID: 33945992]
MGC-803	IC₅₀	8.78 3 Compound: 5	Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by MTT assay	[PMID: 33945992]
Vero C1008	CC₅₀	> 200 3 Compound: Baicalin	Cytotoxicity against African green monkey Vero E6 cells incubated for 3 hrs by CCK-8 assay Cytotoxicity against African green monkey Vero E6 cells incubated for 3 hrs by CCK-8 assay	[PMID: 33186044]
Calu-3	CC₅₀	> 100 3 Compound: Baicalin	Cytotoxicity against human Calu-3 cells incubated for 4 days by MTS assay Cytotoxicity against human Calu-3 cells incubated for 4 days by MTS assay	[PMID: 37437351]
H9	EC₅₀	112 3 Compound: 8	Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay	[PMID: 8158164]
MGC-803	IC₅₀	8.78 3 Compound: 50	Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 5 days by MTT assay Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 5 days by MTT assay	[PMID: 33619958]
RAW264.7	IC₅₀	156.8 3 Compound: 1	Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as reduction in NO production Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as reduction in NO production	[PMID: 37778427]
H9	IC₅₀	72 3 Compound: 8	Cytotoxicity against human H9 cells after 3 days Cytotoxicity against human H9 cells after 3 days	[PMID: 8158164]
RAW264.7	IC₅₀	35.2 6 Compound: 1	Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction in NO production compound photoirradiated using 50 kGy gamma-ray Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction in NO production compound photoirradiated using 50 kGy gamma-ray	[PMID: 37778427]
HEK-293T	CC₅₀	<= 300 3 Compound: Baicalin	Cytotoxicity against HEK293T cells expressing human ACE2 assessed as reduction in cell viability incubated for 4 hrs by MTT assay Cytotoxicity against HEK293T cells expressing human ACE2 assessed as reduction in cell viability incubated for 4 hrs by MTT assay	[PMID: 37437351]
Vero	IC₅₀	13.5 6 Compound: 74	Antiviral activity against DENV2 infected in African green monkey Vero cells by focus formation unit reduction assay Antiviral activity against DENV2 infected in African green monkey Vero cells by focus formation unit reduction assay	[PMID: 31128447]
Vero C1008	CC₅₀	>100 3 Compound: 2	Cytotoxicity against african green monkey Vero E6 cells assessed as inhibition of cell growth incubated for 4 days by MTS assay Cytotoxicity against african green monkey Vero E6 cells assessed as inhibition of cell growth incubated for 4 days by MTS assay	[PMID: 36965227]
Vero C1008	CC₅₀	>200 3 Compound: Baicalin	Cytotoxicity against African green monkey Vero E6 cells incubated for 3 hrs by CCK-8 assay Cytotoxicity against African green monkey Vero E6 cells incubated for 3 hrs by CCK-8 assay	[PMID: 33186044]
HUVEC	IC₅₀	> 1000 3 Compound: 2	Inhibition of trypsin-induced elevation in PAI1 production in HUVEC by ELISA Inhibition of trypsin-induced elevation in PAI1 production in HUVEC by ELISA	[PMID: 9214730]
MGC-803	IC₅₀	8.78 3 Compound: 5	Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by MTT assay	[PMID: 33945992]
MGC-803	IC₅₀	8.78 3 Compound: 50	Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 5 days by MTT assay Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 5 days by MTT assay	[PMID: 33619958]
RAW264.7	IC₅₀	156.8 3 Compound: 1	Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as reduction in NO production Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as reduction in NO production	[PMID: 37778427]
RAW264.7	IC₅₀	35.2 6 Compound: 1	Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction in NO production compound photoirradiated using 50 kGy gamma-ray Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction in NO production compound photoirradiated using 50 kGy gamma-ray	[PMID: 37778427]
Vero	CC₅₀	> 100 3 Compound: Baicalin	Cytotoxicity against African green monkey Vero cells incubated for 4 days by MTS assay Cytotoxicity against African green monkey Vero cells incubated for 4 days by MTS assay	[PMID: 37437351]
Vero	CC₅₀	> 200 3 Compound: Baicalin	Cytotoxicity against African green monkey Vero cells Cytotoxicity against African green monkey Vero cells	[PMID: 37437351]
Vero	IC₅₀	13.5 6 Compound: 74	Antiviral activity against DENV2 infected in African green monkey Vero cells by focus formation unit reduction assay Antiviral activity against DENV2 infected in African green monkey Vero cells by focus formation unit reduction assay	[PMID: 31128447]
Vero C1008	CC₅₀	> 100 3 Compound: 2	Cytotoxicity against african green monkey Vero E6 cells assessed as inhibition of cell growth incubated for 4 days by MTS assay Cytotoxicity against african green monkey Vero E6 cells assessed as inhibition of cell growth incubated for 4 days by MTS assay	[PMID: 36965227]
Vero C1008	CC₅₀	> 1000 3 Compound: Baicalin	Cytotoxicity against African green monkey Vero E6 cells assessed as reduction in cell viability incubated for 3 days by MTT assay Cytotoxicity against African green monkey Vero E6 cells assessed as reduction in cell viability incubated for 3 days by MTT assay	[PMID: 37437351]
Vero C1008	CC₅₀	> 200 3 Compound: 85	Cytotoxicity against African green monkey Vero E6 cells assessed as reduction in cell growth incubated for 24 hrs by WST-8 assay Cytotoxicity against African green monkey Vero E6 cells assessed as reduction in cell growth incubated for 24 hrs by WST-8 assay	[PMID: 37597436]
Vero C1008	CC₅₀	> 200 3 Compound: Baicalin	Cytotoxicity against African green monkey Vero E6 cells incubated for 3 hrs by CCK-8 assay Cytotoxicity against African green monkey Vero E6 cells incubated for 3 hrs by CCK-8 assay	[PMID: 33186044]

In Vitro

Baicalin protects against ischemia-reperfusion injury (IRI) by altering the production of various mediators, including reactive oxygen species (ROS), Toll-like receptor (TLR)2 and TLR4, NF-κB, Bax, and Bcl-2. Baicalin treatment inhibits the increased expression of the proinflammatory cytokines TLR2/4, MyD88, p-NF-κB, and p- IκB, as well as increase the expression of IκB protein, an NF-κB inhibitor^[1].
Cell viability is determined by MTT assay. Compared with control cells, cell viability is significantly decreased in SH-SY5Y cells treated with thrombin. Pre-treatment with Baicalin (5, 10, 20 μM) increases cell viability in a dose-dependent manner compared with cells treated thrombin alone^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Baicalin pretreatment dose-dependently protects against a loss of renal function, with the two higher doses (10 and 100 mg/kg) significantly decreasing Scr and blood urea nitrogen (BUN) concentrations. Tissue injury, as assessed using a 0-3 point scoring system, is lower for the Baicalin treated groups than for the ischemia-reperfusion (IR)+saline group. Compared with the sham group, malondialdehyde (MDA) content is only slightly up-regulated and the SOD activity is only slightly down-regulated in rats treated with 10 and 100 mg/kg Baicalin, indicating that Baicalin abrogates the increase in oxidative stress following reperfusion^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

분자량

446.36

화학식

C₂₁H₁₈O₁₁

CAS No.

21967-41-9

Appearance

Solid

Color

Light yellow to yellow

SMILES

O[C@H]([C@H]([C@@H]([C@@H](C(O)=O)O1)O)O)[C@@H]1OC2=C(O)C(O)=C3C(C=C(C4=CC=CC=C4)OC3=C2)=O

Structure Classification

Initial Source

선적

Room temperature in continental US; may vary elsewhere.

보관

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	1 year
	-20°C	6 months

용액&용해도

In Vitro:

DMSO : ≥ 100 mg/mL (224.03 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H₂O : < 0.1 mg/mL (insoluble)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.2403 mL	11.2017 mL	22.4034 mL
5 mM	0.4481 mL	2.2403 mL	4.4807 mL
10 mM	0.2240 mL	1.1202 mL	2.2403 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

몰농도 계산기
농도 희석 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (5.60 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (5.60 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 0.5% CMC-Na/saline water
Solubility: 20 mg/mL (44.81 mM); Suspended solution; Need ultrasonic

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

순도&문서

Purity: 98.92%

Select Batch:

Data Sheet (283 KB) SDS (396 KB)

COA (252 KB) LCMS (142 KB)

Handling Instructions (2659 KB)

References

[1]. Lin M, et al. The protective effect of Baicalin against renal ischemia-reperfusion injury through inhibition of inflammation and apoptosis. BMC Complement Altern Med. 2014 Jan 13;14:19. [Content Brief]

[2]. Ju XN, et al. Baicalin protects against thrombin induced cell injury in SH-SY5Y cells. Int J Clin Exp Pathol. 2015 Nov 1;8(11):14021-7. [Content Brief]

[3]. Dai J, et al. Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis. Proc Natl Acad Sci U S A. 2018;115(26):E5896-E5905. [Content Brief]

Cell Assay ^[2]	SH-SY5Y cell lines are cultured in RPMI-1640 medium supplemented with 15% fetal bovine serum at 37°C in an air atmosphere containing 95% air and 5% CO₂ with a saturated humidity. Upon a confluence of 60~70%, the SH-SY5Y cells are divided into: (i) control group, incubated in RPMI-1640 medium; (ii) thrombin group, which is subject to thrombin induction (40 U/L) for 6 h based on our pre-experiment; and (iii) Baicalin groups, which are treated by Baicalin (5 μM, 10 μM, or 20 μM) for 2 h before induction of thrombin. Cell viability is measured using MTT assay. Briefly, 15 μL of the MTT solution (5 mg/mL) is added to each well and incubated for 4 h at 37°C. After removing the supernatant, 80 μL DMSO are added into each well. The absorbance is measured at 492 nm using a microplate reader. All experiments are performed in triplicate^[2]. MCE 는 독립적으로 이러한 방법들의 정확성을 확인하지 않았습니다. 참고용으로만 봐주십시오.
Animal Administration ^[1]	Rats^[1] Male Wistar rats weighing 200-250 g are used. Rats are randomly divided into five groups of six rats each: (i) sham group; (ii) IR+saline group; (iii) IR+Baicalin (1 mg/kg) group; (iv) IR+Baicalin (10 mg/kg) group; and (v) IR+Baicalin (100 mg/kg) group. Renal IRI is induced by clamping the left renal artery for 45 min plus a right nephrectomy. Rats are anesthetized through an intraperitoneal injection of pentobarbital sodium (40 mg/kg body weight). After a median abdominal incision, the left renal arteries are clamped for 45 min with serrefine. After clamp removal, adequate restoration of blood flow is checked before abdominal closure. The right kidney is then removed. Sham-operated animals underwent the same surgical procedure without clamping^[1]. MCE 는 독립적으로 이러한 방법들의 정확성을 확인하지 않았습니다. 참고용으로만 봐주십시오.
References	[1]. Lin M, et al. The protective effect of Baicalin against renal ischemia-reperfusion injury through inhibition of inflammation and apoptosis. BMC Complement Altern Med. 2014 Jan 13;14:19. [Content Brief] [2]. Ju XN, et al. Baicalin protects against thrombin induced cell injury in SH-SY5Y cells. Int J Clin Exp Pathol. 2015 Nov 1;8(11):14021-7. [Content Brief] [3]. Dai J, et al. Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis. Proc Natl Acad Sci U S A. 2018;115(26):E5896-E5905. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.2403 mL	11.2017 mL	22.4034 mL	56.0086 mL
	5 mM	0.4481 mL	2.2403 mL	4.4807 mL	11.2017 mL
	10 mM	0.2240 mL	1.1202 mL	2.2403 mL	5.6009 mL
	15 mM	0.1494 mL	0.7468 mL	1.4936 mL	3.7339 mL
	20 mM	0.1120 mL	0.5601 mL	1.1202 mL	2.8004 mL
	25 mM	0.0896 mL	0.4481 mL	0.8961 mL	2.2403 mL
	30 mM	0.0747 mL	0.3734 mL	0.7468 mL	1.8670 mL
	40 mM	0.0560 mL	0.2800 mL	0.5601 mL	1.4002 mL
	50 mM	0.0448 mL	0.2240 mL	0.4481 mL	1.1202 mL
	60 mM	0.0373 mL	0.1867 mL	0.3734 mL	0.9335 mL
	80 mM	0.0280 mL	0.1400 mL	0.2800 mL	0.7001 mL
	100 mM	0.0224 mL	0.1120 mL	0.2240 mL	0.5601 mL

Baicalin Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Baicalin21967-41-9Baicalein 7-O-β-D-glucuronideCarnitine Palmitoyltransferase (CPT)NF-κBAutophagyHIVCarnitine O-palmitoyltransferaseNuclear factor-κBNuclear factor-kappaBHuman immunodeficiency virusInhibitorinhibitorinhibit

Please select a local distributor ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
상품명			Requested Quantity *
고객명 *			호칭
메일주소 *			전화번호 *
Department			회사명 *
City			도
Country or Region *
비고

상품명			Lot #
고객명 *			메일주소 *
전화번호			Department *
회사명 *			Country or Region *
비고

Name
이메일 *

	Sorry, but the email address you supplied was invalid.

Baicalin (Synonyms: Baicalein 7-O-β-D-glucuronide)

고객리뷰

Other Forms of Baicalin:

Baicalin Related Antibodies

60 Publications Citing Use of MCE Baicalin

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All NF-κB Isoform Specific Products:

View All HIV Isoform Specific Products:

Biological Activity

Protocol

순도&문서

References

고객리뷰

Baicalin Related Antibodies

몰농도 계산기

농도 희석 계산기

Complete Stock Solution Preparation Table

Baicalin Related Classifications

Keywords:

최근 본 상품:

고객리뷰

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report